| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 17,183 | 16,491 | 17,443 | 21,337 | | Cost of Revenue | 10,453 | 10,302 | 11,256 | 13,974 | | | Gross Profit | 6,730 | 6,189 | 6,187 | 7,363 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,993 | 6,916 | 6,501 | 6,741 | | Non Recurring |
-
|
-
|
-
| 66,568 | | Others | 432 | 423 | 417 | (242) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 305 | (1,150) | (731) | (65,704) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 1 |
-
|
-
| | Earnings Before Interest And Taxes | 305 | (1,149) | (731) | (64,870) | | Interest Expense | 82 | 40 | 23 | 10 | | Income Before Tax | 223 | (1,189) | (754) | (64,880) | | Income Tax Expense | 88 | (438) | (222) | (1,011) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 135 | (751) | (532) | (64,703) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 135 | (751) | (532) | (64,703) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $135 | ($751) | ($532) | ($64,703) |
|
0.21% Nasdaq 
Income Statement
